PlainPharmaWatch

CMS Open Payments · Program Year 2024

Materialise USA LLC

Materialise USA LLC reported $273.65 across General Payments, Research, and Ownership to 6 physicians and teaching hospitals across 6 transactions.

$273.65
All-tracks total
6
Transactions
6
Recipients
+$209.82
General Payments vs PY2023

Materialise USA LLC reported $273.65 across all CMS Open Payments tracks (General + Research + Ownership) to 6 physicians and teaching hospitals in Program Year 2024 - ranking #1891 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $273.65, averaging $45.61 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer materialise-usa-llc Materialise USA LLC

$273.65 · #1891/1,925 · 0.0% industry · PY2024

  • TOT $273.65
  • RANK #1891
  • SHARE 0.0%
  • TXN 6
  • RCP 6
  • CAT 1
  • GEN $273.65
  • ΔGEN +$209.82
  • TOP1 55.0%
  • PY 2024

Nearest volume peer: McKesson Specialty Care Distribution, LLC ($271.93)

Teleflex Medical Canada Inc.$289.56Materialise USA LLC (this)$273.65McKesson Specialty Care Dist…$271.93AmerisourceBergen Drug Corpo…$268.97PARI Respiratory Equipment, …$262.70
All-tracks payment totals near Materialise USA LLC (CMS Open Payments PY2024)

Materialise USA LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Materialise USA LLC's CMS-reported General Payments increased by $209.82 (+328.7%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: MATERIALISE USA LLCPY2023: MATERIALISE USA LLCPY2024: Materialise USA LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$63.83PY2024$273.65
PY2023
$63.83
PY2024
$273.65

What the Data Shows for Materialise USA LLC

$273.65: that is what Materialise USA LLC reported in payments to 6 physicians and teaching hospitals during Program Year 2024, spread across 6 transactions ($45.61 per transaction, $45.61 per recipient). The company sits at rank #1891 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $273.65 across 6 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Materialise USA LLC made 1 types of general payments. "Food and Beverage" is the largest category at $273.65, 100.0% of General Payments.

How Materialise USA LLC divides its payments

How the reported total splits across payment categories

1. Food and Beverage$273.65
Payment Type Amount Transactions
Food and Beverage $273.65 6

Recipient Concentration in General Payments

The five largest recipient relationships account for $273.65 (100.0%) of $273.65 in this company's General Payments records across 4 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Materialise USA LLC

The five named recipients with the highest reported General Payments from this company

Richard Ohye$150.42Elsa Arribas$73.79Michael Pearl$30.94Julia Sanders$18.50
  1. 1

    Richard Ohye

    $150.42 across 2 reported transactions

  2. 2

    Elsa Arribas

    $73.79 across 2 reported transactions

  3. 3

    Michael Pearl

    $30.94 across 1 reported transactions

  4. 4

    Julia Sanders

    $18.50 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Materialise USA LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Materialise USA LLC.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Materialise USA LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Materialise USA LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.